Patents by Inventor Meena Ramachandran
Meena Ramachandran has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11957459Abstract: Subject matter disclosed herein relates to monitoring and/or controlling blood glucose levels in patients. In particular, times for obtaining metered blood glucose samples of a patient may be altered based, at least in part, on a blood glucose level of said patient observed from a blood glucose sensor.Type: GrantFiled: December 15, 2021Date of Patent: April 16, 2024Assignee: Medtronic MiniMed, Inc.Inventors: Rebecca K. Gottlieb, Meena Ramachandran
-
Publication number: 20220104734Abstract: Subject matter disclosed herein relates to monitoring and/or controlling blood glucose levels in patients. In particular, times for obtaining metered blood glucose samples of a patient may be altered based, at least in part, on a blood glucose level of said patient observed from a blood glucose sensor.Type: ApplicationFiled: December 15, 2021Publication date: April 7, 2022Inventors: Rebecca K. Gottlieb, Meena Ramachandran
-
Patent number: 11224362Abstract: Subject matter disclosed herein relates to monitoring and/or controlling blood glucose levels in patients. In particular, times for obtaining metered blood glucose samples of a patient may be altered based, at least in part, on a blood glucose level of said patient observed from a blood glucose sensor.Type: GrantFiled: September 3, 2019Date of Patent: January 18, 2022Assignee: MEDTRONIC MINIMED, INC.Inventors: Rebecca K. Gottlieb, Meena Ramachandran
-
Publication number: 20190388014Abstract: Subject matter disclosed herein relates to monitoring and/or controlling blood glucose levels in patients. In particular, times for obtaining metered blood glucose samples of a patient may be altered based, at least in part, on a blood glucose level of said patient observed from a blood glucose sensor.Type: ApplicationFiled: September 3, 2019Publication date: December 26, 2019Inventors: Rebecca K. Gottlieb, Meena Ramachandran
-
Patent number: 10433774Abstract: Subject matter disclosed herein relates to monitoring and/or controlling blood glucose levels in patients. In particular, times for obtaining metered blood glucose samples of a patient may be altered based, at least in part, on a blood glucose level of said patient observed from a blood glucose sensor.Type: GrantFiled: September 16, 2016Date of Patent: October 8, 2019Assignee: Medtronic Minimed, Inc.Inventors: Rebecca K. Gottlieb, Meena Ramachandran
-
Patent number: 10429395Abstract: Disclosed are methods, apparatuses, etc. for glucose sensor signal stability analysis. In certain example embodiments, a series of samples of at least one sensor signal that is responsive to a blood glucose level of a patient may be obtained. Based at least partly on the series of samples, at least one metric may be determined to assess an underlying trend of a change in responsiveness of the at least one sensor signal to the blood glucose level of the patient over time. A reliability of the at least one sensor signal to respond to the blood glucose level of the patient may be assessed based at least partly on the at least one metric assessing the underlying trend. Other example embodiments are disclosed herein.Type: GrantFiled: July 10, 2015Date of Patent: October 1, 2019Assignee: Medtronic Minimed, Inc.Inventors: Ying Luo, Rebecca K. Gottlieb, Meena Ramachandran, Chia-Hung Chiu, Nandita Dangui-Patel, Michael Kremliovsky, Jefferson Rose
-
Publication number: 20170065212Abstract: Subject matter disclosed herein relates to monitoring and/or controlling blood glucose levels in patients. In particular, times for obtaining metered blood glucose samples of a patient may be altered based, at least in part, on a blood glucose level of said patient observed from a blood glucose sensor.Type: ApplicationFiled: September 16, 2016Publication date: March 9, 2017Inventors: Rebecca K. Gottlieb, Meena Ramachandran
-
Patent number: 9215995Abstract: Embodiments of the invention provide amperometric analyte sensors having multiple related structural elements (e.g. sensor arrays comprising a working, counter and reference electrode) and algorithms designed for use with such sensors. While embodiments of the innovation can be used in a variety of contexts, typical embodiments of the invention include glucose sensors used in the management of diabetes.Type: GrantFiled: June 21, 2011Date of Patent: December 22, 2015Assignee: Medtronic MiniMed, Inc.Inventors: Rebecca K. Gottlieb, Chia-Hung Chiu, Meena Ramachandran, Nandita Dangui-Patel, Jefferson Rose, Ashwin K. Rao, Hsifu Wang, Ying Luo
-
Publication number: 20150316559Abstract: Disclosed are methods, apparatuses, etc. for glucose sensor signal stability analysis. In certain example embodiments, a series of samples of at least one sensor signal that is responsive to a blood glucose level of a patient may be obtained. Based at least partly on the series of samples, at least one metric may be determined to assess an underlying trend of a change in responsiveness of the at least one sensor signal to the blood glucose level of the patient over time. A reliability of the at least one sensor signal to respond to the blood glucose level of the patient may be assessed based at least partly on the at least one metric assessing the underlying trend. Other example embodiments are disclosed herein.Type: ApplicationFiled: July 10, 2015Publication date: November 5, 2015Inventors: Ying Luo, Rebecca K. Gottlieb, Meena Ramachandran, Chia-Hung Chiu, Nandita Dangui-Patel, Michael Kremliovsky, Jefferson Rose
-
Patent number: 9101310Abstract: Disclosed are methods, apparatuses, etc. for glucose sensor signal stability analysis. In certain example embodiments, a series of samples of at least one sensor signal that is responsive to a blood glucose level of a patient may be obtained. Based at least partly on the series of samples, at least one metric may be determined to assess an underlying trend of a change in responsiveness of the at least one sensor signal to the blood glucose level of the patient over time. A reliability of the at least one sensor signal to respond to the blood glucose level of the patient may be assessed based at least partly on the at least one metric assessing an underlying trend. Other example embodiments are disclosed herein.Type: GrantFiled: August 30, 2013Date of Patent: August 11, 2015Assignee: Medtronic Minimed, Inc.Inventors: Ying Luo, Rebecca K. Gottlieb, Meena Ramachandran, Chia-Hung Chiu, Nandita Dangui-Patel, Michael Kremliovsky, Jefferson Rose
-
Publication number: 20140000338Abstract: Disclosed are methods, apparatuses, etc. for glucose sensor signal stability analysis. In certain example embodiments, a series of samples of at least one sensor signal that is responsive to a blood glucose level of a patient may be obtained. Based at least partly on the series of samples, at least one metric may be determined to assess an underlying trend of a change in responsiveness of the at least one sensor signal to the blood glucose level of the patient over time. A reliability of the at least one sensor signal to respond to the blood glucose level of the patient may be assessed based at least partly on the at least one metric assessing an underlying trend. Other example embodiments are disclosed herein.Type: ApplicationFiled: August 30, 2013Publication date: January 2, 2014Applicant: Medtronic MiniMed, Inc.Inventors: Ying Luo, Rebecca K. Gottlieb, Meena Ramachandran, Chia-Hung Chiu, Nandita Dangui-Patel, Michael Kremliovsky, Jefferson Rose
-
Patent number: 8543354Abstract: Disclosed are methods, apparatuses, etc. for glucose sensor signal stability analysis. In certain example embodiments, a series of samples of at least one sensor signal that is responsive to a blood glucose level of a patient may be obtained. Based at least partly on the series of samples, at least one metric may be determined to assess an underlying trend of a change in responsiveness of the at least one sensor signal to the blood glucose level of the patient over time. A reliability of the at least one sensor signal to respond to the blood glucose level of the patient may be assessed based at least partly on the at least one metric assessing an underlying trend. Other example embodiments are disclosed herein.Type: GrantFiled: October 28, 2010Date of Patent: September 24, 2013Assignee: Medtronic Minimed, Inc.Inventors: Ying Luo, Rebecca K. Gottlieb, Meena Ramachandran, Chia-Hung Chiu, Nandita Dangui-Patel, Michael Kremliovsky, Jefferson Rose
-
Publication number: 20120006100Abstract: Subject matter disclosed herein relates to monitoring and/or controlling blood glucose levels in patients. In particular, times for obtaining metered blood glucose samples of a patient may be altered based, at least in part, on a blood glucose level of said patient observed from a blood glucose sensor.Type: ApplicationFiled: June 28, 2011Publication date: January 12, 2012Applicant: Medtronic Minimed, Inc.Inventors: Rebecca K. Gottlieb, Meena Ramachandran
-
Publication number: 20110319734Abstract: Embodiments of the invention provide amperometric analyte sensors having multiple related structural elements (e.g. sensor arrays comprising a working, counter and reference electrode) and algorithms designed for use with such sensors. While embodiments of the innovation can be used in a variety of contexts, typical embodiments of the invention include glucose sensors used in the management of diabetes.Type: ApplicationFiled: June 21, 2011Publication date: December 29, 2011Applicant: MEDTRONIC MINIMED, INC.Inventors: Rebecca K. Gottlieb, Chia-Hung Chiu, Meena Ramachandran, Nandita Dangui-Patel, Jefferson Rose, Ashwin K. Rao, Hsifu Wang, Ying Luo
-
Publication number: 20110320166Abstract: Disclosed are methods, apparatuses, etc. for glucose sensor signal stability analysis. In certain example embodiments, a series of samples of at least one sensor signal that is responsive to a blood glucose level of a patient may be obtained. Based at least partly on the series of samples, at least one metric may be determined to assess an underlying trend of a change in responsiveness of the at least one sensor signal to the blood glucose level of the patient over time. A reliability of the at least one sensor signal to respond to the blood glucose level of the patient may be assessed based at least partly on the at least one metric assessing an underlying trend. Other example embodiments are disclosed herein.Type: ApplicationFiled: October 28, 2010Publication date: December 29, 2011Applicant: Medtronic Minimed, Inc.Inventors: Ying Luo, Rebecca K. Gottlieb, Meena Ramachandran, Chia-Hung Chiu, Nandita Dangui-Patel, Michael Kremliovsky, Jefferson Rose
-
Publication number: 20100087731Abstract: A tubular stent formed from a plurality of filaments, the filaments constructed out of a solid bioabsorbable polymeric material having active agent particles dispersed there through that are visible by magnetic resonance imaging (MRI). The active agent particles are superparamagnetic iron oxide (SPIO) particles. The SPIO particles enhance the visibility of the polymeric stent under MRI, and also allow for accurate monitoring of stent degradation. As the stent degrades, the SPIO particles are released and either flow downstream or are embedded by nearby macrophages. The amount of SPIO particles within the remaining stent body is decreased, which results in a different MRI signal. By quantifying the signal change, the amount of biodegradable stent remaining can be deduced in situ and the stent degradation rate may be accurately calculated.Type: ApplicationFiled: October 7, 2008Publication date: April 8, 2010Applicant: Medtronic Vascular, Inc.Inventor: Meena Ramachandran
-
Publication number: 20080255606Abstract: A filtering apparatus for collecting emboli or thromboli in a body lumen. The apparatus may be a temporary filtering device mounted on a core wire for use during interventional procedures or a semi-permanent filtering device that is left within a body lumen for a therapeutically appropriate length of time. The filtering device includes a tubular member having an outer surface for apposition with the body lumen and a filter member positioned within an interior of the tubular member. The fitter member includes an apex at a proximal end that is positioned along a longitudinal axis of the filtering device, a distal end attached to the tubular member, and an outer surface facing an inner surface of the tubular member.Type: ApplicationFiled: April 16, 2007Publication date: October 16, 2008Applicant: Medtronic Vascular, Inc.Inventors: Ashish Mitra, Meena Ramachandran, Karan Punga